Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at 3 cycles of chemotherapy for urothelial cancer (urinary tract cancer) (DISCUS)

Overview

Cancer types:

Bladder cancer, Kidney cancer

Status:

Open

Phase:

Phase 2

Details

This trial is comparing 3 with the standard 6 cycles for urinary tract cancer that has spread.

It is for people who:

  • have urothelial cancer that has grown into nearby tissues or has spread to another part of the body

  • are going to have an called avelumab after chemotherapy

Recruitment start: 12 December 2021

Recruitment end: 30 April 2026

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Thomas Powles

Supported by

Merck

Queen Mary University of London

Last reviewed: 08 Jan 2026

CRUK internal database number: 18104

Help and support